AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
Florida Cancer Specialists - South ( Site 7004), Fort Myers
Bioresearch Partner ( Site 0072), Hialeah
in še 2

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06966700

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Mayo Clinic Jacksonville, Jacksonville
Moffitt Cancer Center, Tampa

Vključevanje udeležencevOpazovalna študija

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT04981119

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs
Orlando Health Cancer Institute ( Site 0030), Orlando
Comprehensive Hematology Oncology ( Site 0091), St. Petersburg
in še 1

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06393374

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs
Orlando Health Cancer Institute ( Site 0012), Orlando
Florida Cancer Specialists - East ( Site 7000), West Palm Beach

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06841354

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Morton Plant Hospital - Baycare Health System, Clearwater
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05528133

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT06618287

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Sylvester Comprehensive Cancer Center, Miami
Sara Cannon Research Institute Lake Nona, Orlando
Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT05983432

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Biogenix Molecular, LLC, Miami
Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT07020117

Study of Screening Brain MRIs in Stage IV Breast Cancer

Morton Plant Mease- Baycare, Clearwater

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT05115474

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

University of Miami, Miami

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 11. sep. 2026 · NCT06657222

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

Mayo Clinic Florida, Jacksonville
Cancer Specialists of North Florida, Jacksonville
Jupiter Medical Center, Jupiter
in še 4

Vključevanje udeležencevFaza 3

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT05633654

Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
in še 7

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT03606967

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

BAPTIST ALLIANCE - MCI (Data Collection Only), Miami

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT05570253

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

Cleveland Clinic Florida, Weston

Vključevanje udeležencevOpazovalna študija

Starost 18–99 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

SCRI Florida Cancer Specialists - Sarasota, Sarasota

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. avg. 2026 · NCT07029399

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Mayo Clinic in Florida, Jacksonville

Vključevanje udeležencevFaza 1/2

Starost 16 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT05269381

SMP-3124LP in Adults With Advanced Solid Tumors

Advent Health, Celebration

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT06526819

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Local Institution - 0296, Pembroke Pines

Vključevanje udeležencevFaza 2/3

Starost 18 in več · Vsi spoli · Posodobljeno 10. avg. 2026 · NCT06926868

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Miami Baptist Cancer Institute/, Miami

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 6. avg. 2026 · NCT06176261

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

USOR Florida Cancer Specialists South, Fort Myers
USOR Florida Cancer Specialists North, St. Petersburg
USOR Florida Cancer Specialists East, West Palm Beach

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 4. avg. 2026 · NCT05579366

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Mayo Clinic Jacksonville, Jacksonville

Vključevanje udeležencevFaza 1

Starost 18–100 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06562192

A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Florida Cancer Specialists - Lake Nona, Orlando
Florida Cancer Specialists - Sarasota, Sarasota

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT06150664

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Mayo Clinic - Jacksonville, Jacksonville
Florida Cancer Specialists, Sarasota
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 29. jun. 2026 · NCT05377996

A Study of LY4175408 in Participants With Advanced Cancer

Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Florida Cancer Specialists - Sarasota, Sarasota

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923

Study of XB010 in Subjects With Solid Tumors

Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 22. jun. 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Florida Cancer Specialists, Sarasota

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 18. jun. 2026 · NCT07503808

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

University of Miami Health System, Coral Gables

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 15. jun. 2026 · NCT05768932

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 11. jun. 2026 · NCT05076760

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Moffitt Cancer Center and Research Institute, Tampa

Vključevanje udeležencevFaza 1/2

Starost 18 in več · Vsi spoli · Posodobljeno 4. jun. 2026 · NCT04300556

Phase 1 Study of CLR 125 in Triple Negative Breast Cancer

Mayo Clinic Florida, Jacksonville

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT07311993

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute, Tampa
Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 6. maj 2026 · NCT01042379

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Miami Cancer Institute at Baptist Health (Kendall), Miami
Miami Cancer Institute at Baptist Health, Plantation

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 29. apr. 2026 · NCT04468061

Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Moffitt Cancer Center, Tampa

Vključevanje udeležencevZgodnja faza 1

Starost 18 in več · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT06435351

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Baptist Alliance - McI, Miami

Vključevanje udeležencevFaza 2

Starost 18 in več · Vsi spoli · Posodobljeno 27. feb. 2026 · NCT03808337

DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer

Moffitt Cancer Center, Tampa

Vključevanje udeležencevFaza 1

Starost 18 in več · Vsi spoli · Posodobljeno 5. feb. 2026 · NCT05504707

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.